Foundation Resource Management Inc Organon & Co. Transaction History

Foundation Resource Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$16.59 - $23.77 $27,423 - $39,291	-1,653 Reduced 11.71%	12,462 $216,000
Q2 2023 Jul 12, 2023	SELL	$19.27 - $24.63 $3,988 - $5,098	-207 Reduced 1.45%	14,115 $294,000
Q1 2023 Apr 11, 2023	SELL	$21.42 - $32.08 $15,872 - $23,771	-741 Reduced 4.92%	14,322 $337,000
Q4 2022 Jan 12, 2023	SELL	$23.31 - $28.61 $2,983 - $3,662	-128 Reduced 0.84%	15,063 $421,000
Q3 2022 Oct 13, 2022	SELL	$23.4 - $34.25 $95,401 - $139,637	-4,077 Reduced 21.16%	15,191 $355,000
Q2 2022 Jul 15, 2022	SELL	$31.66 - $38.9 $54,423 - $66,869	-1,719 Reduced 8.19%	19,268 $650,000
Q1 2022 Apr 12, 2022	SELL	$30.45 - $39.36 $7,338 - $9,485	-241 Reduced 1.14%	20,987 $733,000
Q4 2021 Jan 21, 2022	SELL	$28.67 - $37.13 $608,606 - $788,195	-21,228 Reduced 50.0%	21,228 $646,000
Q4 2021 Jan 12, 2022	BUY	$28.67 - $37.13 $589,053 - $762,872	20,546 Added 93.77%	42,456 $1.29 Million
Q3 2021 Oct 12, 2021	SELL	$28.63 - $35.64 $4,294 - $5,346	-150 Reduced 0.68%	21,910 $718,000
Q2 2021 Jul 13, 2021	BUY	$28.45 - $38.0 $627,607 - $838,280	22,060 New	22,060 $668,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

Stay updated on Foundation Resource Management Inc with notifications on news.